Teva Pharmaceutical Beats Q3 Estimates and Raises Annual Revenue Guidance
TEVA Teva- Pharmaceutical Industries Ltd
$43.24 +1.98%
View chart & analysis → - 1Teva Pharmaceutical's third-quarter revenue reached $4.395 billion, exceeding expectations by 2.7%.
- 2The third-quarter adjusted EPS of $0.83 from Earnings Whispers is 18.6% higher than the consensus.
- 3Teva Pharmaceutical has raised its annual revenue guidance for the third consecutive time.
So what's the key point?
Teva Pharmaceutical's third-quarter revenue was 2.7% higher than what experts expected. The company also raised its outlook for yearly revenue for the third time.
Source Earnings Whispers · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.